Note to Readers: Feb 18, 2013

Feb 18, 2013 | staff reporter

NOTE TO READERS: GenomeWeb Daily News will publish one bulletin today, Feb. 18, in observance of Presidents Day in the US. We will resume publishing twice-daily bulletins on Tuesday, Feb. 19.

Breaking News

New Products Posted to GenomeWeb: ConcertAI, NeoGenomics, Quantum-Si, Alithea Genomics, More
International Consensus Statement Says Microbiome-Based Diagnostic Tests Not Ready for Prime Time
People in the News at Delfi Diagnostics, AcuamarkDx, Exai Bio, Evotec, Watchmaker Genomics
Updated NCCN Guidelines Adjust Ratings for Prostate Cancer Genetic Tests
In Brief This Week: Myriad Genetics, Europa Biosite, Mount Sinai, DeepUll, Thermo Fisher, More

Note to Readers: Feb 18, 2013

New Products Posted to GenomeWeb: ConcertAI, NeoGenomics, Quantum-Si, Alithea Genomics, More

International Consensus Statement Says Microbiome-Based Diagnostic Tests Not Ready for Prime Time

People in the News at Delfi Diagnostics, AcuamarkDx, Exai Bio, Evotec, Watchmaker Genomics

Updated NCCN Guidelines Adjust Ratings for Prostate Cancer Genetic Tests

In Brief This Week: Myriad Genetics, Europa Biosite, Mount Sinai, DeepUll, Thermo Fisher, More

Oxford Nanopore Technologies Sues BGI, Affiliates for Sequencing Technology Contract Breach

International Consensus Statement Says Microbiome-Based Diagnostic Tests Not Ready for Prime Time

People in the News at Delfi Diagnostics, AcuamarkDx, Exai Bio, Evotec, Watchmaker Genomics

HER2 Biomarker Evolving as Enhertu Shows Activity in Breast Cancers With Ultralow Expression
Premium

In Brief This Week: Myriad Genetics, Europa Biosite, Mount Sinai, DeepUll, Thermo Fisher, More

Note to Readers: Feb 18, 2013

HER2 Biomarker Evolving as Enhertu Shows Activity in Breast Cancers With Ultralow Expression Premium

HER2 Biomarker Evolving as Enhertu Shows Activity in Breast Cancers With Ultralow Expression
Premium